Home » Topics » BioWorld Science

BioWorld Science
RSS

cGMP-PDE inhibitors revealed by Fujisawa

Dec. 11, 1996

HMR describes NK1/NK2 antagonists for respiratory indications

Dec. 11, 1996

Antitumor borneol esters reported by Schering AG

Dec. 11, 1996

LG Chemical describes novel vaccine adjuvant formulation

Dec. 11, 1996

Knoll claims potential anticonvulsants

Dec. 11, 1996

Pharma Mar describes cytotoxic xenicane diterpenes

Dec. 11, 1996

Paracetamol safety established in pregnant mothers and their babies

Dec. 10, 1996

CytRx subsidiary to merge with Zynaxis

Dec. 10, 1996

FDA approves new agent for spasticity

Dec. 10, 1996

FemPatch approved for marketing in U.S.

Dec. 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...